Bernard Arulanandam, Ph.D., M.B.A.
Interim Vice President for Research
Dr. Bernard Arulanandam is the interim Vice President for Research at The University of Texas at San Antonio (UTSA). He is a cellular immunologist and directs a research program that is focused on understanding host-microbe interactions and identifying approaches to induce optimal mucosal protection and immunity. Specifically, Dr. Arulanandam’s research efforts are focused on vaccine development for Chlamydia trachomatis, the leading bacterial sexually transmitted infection and Francisella tularensis, the causative agent of pneumonic tularemia. Dr. Arulanandam’s research accomplishments are demonstrated by his continued funding from the National Institutes of Health, extensive list of research publications, and international recognition.
From 2012 to 2016, Dr. Arulanandam served as the Director of the South Texas Center of Emerging Infectious Diseases and currently directs the DoD Center of Excellence in Infection Genomics that encompasses a research program in microbial genomics and bacterial pathogenesis along with extensive community outreach and training components.
Dr. Arulanandam was appointed as the Assistant Vice President of Research Support in December 2012 and continues to serve in this role. In this capacity, he is involved in promoting and supporting research and scholarly activities at UTSA. In February 2015, Dr. Arulanandam was named a fellow of the American Association for the Advancement of Science (AAAS). He was elected by his peers for the honor, recognizing his scientific and socially distinguished efforts to advance science and its applications.
Dr. Bernard Arulanandam obtained a Ph.D. in microbiology and immunology at the Medical College of Ohio and an executive M.B.A. at The University of Texas at San Antonio.